Related Experiment Video
Updated: Aug 5, 2026
05:52
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
[Inverse association between smoking and idiopathic Parkinson's disease]
R Larumbe1, J J Viñes, F Guillén
1Servicio Docencia, Investigación y Desarrollo Sanitarios, Gobierno de Navarra, Pamplona.
Anales Del Sistema Sanitario De Navarra
|July 30, 2003
Summary
Smoking between ages 20 and 50 appears to have a protective effect against developing idiopathic Parkinson's disease. This study observed an inverse association, suggesting fewer smokers developed the condition.
Area of Science:
- Neuroscience
- Epidemiology
Context:
- Idiopathic Parkinson's disease (IPD) is a neurodegenerative disorder with complex etiology.
- The role of lifestyle factors, such as smoking, in IPD risk is an area of ongoing research.
Purpose:
- To evaluate the association between smoking habits during mid-adulthood (ages 20-50) and the risk of developing idiopathic Parkinson's disease.
Summary:
- A case-control study in Navarra found an inverse association between smoking and IPD risk.
- Increased smoking duration and quantity showed a dose-response relationship, reducing Parkinson's disease risk.
- Reduced glutathione levels were observed in IPD cases, independent of smoking status.
Impact:
- Findings suggest a potential protective effect of smoking against IPD.
- Highlights the importance of considering smoking as a potential confounding or protective factor in Parkinson's research.
- Suggests exploring the underlying biological mechanisms, possibly related to antioxidant status.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...